×
Visit the official NINLARO HCP website to learn how the NINLARO regimen may help. HCPs, explore the real-world...

Ixazomib

Drug
Ixazomib is a drug for the treatment of multiple myeloma, a type of white blood cell cancer, in combination with other drugs. It is taken by mouth in the form of capsules. Common side effects include diarrhea, constipation and low platelet count. Wikipedia
ATC code: L01XG03 (WHO)
Elimination half-life: 9.5 days
Other names: MLN2238
Protein binding: 99%